Anbio Biotechnology Class A Ordinary Shares (NNNN) — Financial Flexibility Index
Anbio Biotechnology Class A Ordinary Shares (NNNN) has a Financial Flexibility Index of 0.93x as of December 2024. Free cash flow of $1.60 Million (operating CF $1.60 Million minus capex $1.67) represents 1% of total liabilities ($1.73 Million). Check NNNN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Anbio Biotechnology Class A Ordinary Shares Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Anbio Biotechnology Class A Ordinary Shares across 5 annual periods. For the full cash flow conversion analysis, see Anbio Biotechnology Class A Ordinary Sha (NNNN) cash conversion ratio.
Annual Financial Flexibility Index for Anbio Biotechnology Class A Ordinary Shares (2021–2025)
Year-by-year free cash flow to debt coverage for Anbio Biotechnology Class A Ordinary Shares. Explore how well can Anbio Biotechnology Class A Ordinary Sha service its debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -76.72x | $-6.74 Million | $-6.74 Million | $87.84K | ▼ -6481.0% |
| 2024 | 1.20x | $2.08 Million | $2.08 Million | $1.73 Million | ▲ +32.9% |
| 2023 | 0.90x | $898.37K | $898.37K | $993.06K | ▼ -71.3% |
| 2022 | 3.15x | $4.45 Million | $4.45 Million | $1.41 Million | ▲ +79.4% |
| 2021 | 1.76x | $4.18 Million | $4.18 Million | $2.38 Million | — |